EvolutionaryScale company logo - Drug Discovery company based in United States
startup

EvolutionaryScale

New York, United States
Founded 2024
30+ employees

About

EvolutionaryScale develops generative AI models for de novo protein design and understanding, most notably the ESM-3 family of protein language models. Their core innovation lies in leveraging large-scale protein sequence data to enable the creation of novel proteins with desired functions – demonstrated by the successful in silico design and synthesis of esmGFP, a fluorescent protein evolved beyond natural limitations. Targeting pharmaceutical companies, biotechnology firms, and academic research labs, EvolutionaryScale provides access to ESM-3 via API and open-source models (ESM-3-open) to accelerate drug discovery and protein engineering efforts, backed by $142M in seed funding.

Technology Focus

drug discovery scientific ai llm

Key People

A
Alex Rives

Quick Stats

Total Raised $142M
Founded 2024
Status private
Type startup